<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl2">
 <label>Table 2</label>
 <caption>
  <p>IC
   <sub>50</sub> values phytochemicals from the leaves of 
   <italic>Acacia sieberiana</italic> and doxorubicin towards of drug sensitive and MDR cancer cells lines after 72 h incubation.
  </p>
 </caption>
 <alt-text id="alttext0045">Table 2</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="2">Cell lines</th>
    <th colspan="7">Samples, IC
     <sub>50</sub> values in μM and degrees of resistance∗ or selectivity index∗∗
     <hr/>
    </th>
   </tr>
   <tr>
    <th>1</th>
    <th>2</th>
    <th>3</th>
    <th>4</th>
    <th>5</th>
    <th>6</th>
    <th>Doxorubicin</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>CCRF-CEM</td>
    <td>51.63 ± 4.23</td>
    <td>64.65 ± 4.89</td>
    <td>20.80 ± 1.76</td>
    <td>
     <bold>10.40 ± 1.17</bold>
    </td>
    <td>58.52 ± 5.28</td>
    <td>
     <bold>10.97 ± 0.97</bold>
    </td>
    <td>
     <bold>0.02 ± 0.00</bold>
    </td>
   </tr>
   <tr>
    <td>CEM/ADR5000
     <break/>Degree of resistance∗
    </td>
    <td>&gt;100</td>
    <td>&gt;100</td>
    <td>18.68 ± 1.25
     <break/>0.90
    </td>
    <td>&gt;100
     <break/>&gt;9.62
    </td>
    <td>18.68 ± 0.64
     <break/>0.32
    </td>
    <td>27.04 ± 1.29
     <break/>2.46
    </td>
    <td>122.96 ± 10.94
     <break/>6,683.00
    </td>
   </tr>
   <tr>
    <td>MDA-MB-231-
     <italic>pcDNA</italic>
    </td>
    <td>&gt;100</td>
    <td>&gt;100</td>
    <td>&gt;100</td>
    <td>&gt;100</td>
    <td>&gt;100</td>
    <td>&gt;100</td>
    <td>
     <bold>0.13 ± 0.01</bold>
    </td>
   </tr>
   <tr>
    <td>MDA-MB-231-
     <italic>BCRP</italic>
     <break/>Degree of resistance
    </td>
    <td>&gt;100 nd</td>
    <td>&gt;100 nd</td>
    <td>&gt;100 nd</td>
    <td>&gt;100 nd</td>
    <td>&gt;100 nd</td>
    <td>&gt;100 nd</td>
    <td>
     <bold>0.79 ± 0.08</bold>
     <break/>6.14
    </td>
   </tr>
   <tr>
    <td>HCT116 (
     <italic>p53</italic>
     <sup>
      <italic>+/+</italic>
     </sup>)
    </td>
    <td>&gt;100</td>
    <td>&gt;100</td>
    <td>30.69 ± 4.04</td>
    <td>&gt;100</td>
    <td>&gt;100</td>
    <td>28.32 ± 1.07</td>
    <td>
     <bold>0.48 ± 0.06</bold>
    </td>
   </tr>
   <tr>
    <td>HCT116 (
     <italic>p53</italic>
     <sup>
      <italic>−/−</italic>
     </sup>)
     <break/>Degree of resistance
    </td>
    <td>&gt;100</td>
    <td>&gt;100</td>
    <td>28.43 ± 1.72
     <break/>0.93
    </td>
    <td>&gt;100</td>
    <td>27.98 ± 1.43
     <break/>&lt;0.28
    </td>
    <td>30.35 ± 2.55
     <break/>1.07
    </td>
    <td>
     <bold>1.78 ± 0.08</bold>
     <break/>3.73
    </td>
   </tr>
   <tr>
    <td>U87MG</td>
    <td>42.48 ± 3.12</td>
    <td>46.71 ± 2.98</td>
    <td>24.92 ± 2.19</td>
    <td>&gt;100</td>
    <td>33.54 ± 2.09</td>
    <td>22.71 ± 2.20</td>
    <td>
     <bold>0.26 ± 0.03</bold>
    </td>
   </tr>
   <tr>
    <td>U87MG.Δ
     <italic>EGFR</italic>
     <break/>Degree of resistance
    </td>
    <td>38.12 ± 3.48
     <break/>0.90
    </td>
    <td>48.22 ± 4.51
     <break/>1.03
    </td>
    <td>21.08 ± 0.92
     <break/>0.85
    </td>
    <td>&gt;100</td>
    <td>27.34 ± 3.12
     <break/>0.82
    </td>
    <td>18.95 ± 1.06
     <break/>0.83
    </td>
    <td>
     <bold>0.98 ± 0.07</bold>
     <break/>3.79
    </td>
   </tr>
   <tr>
    <td>HepG2</td>
    <td>&gt;100</td>
    <td>&gt;100</td>
    <td>34.25 ± 2.86</td>
    <td>&gt;100</td>
    <td>27.93 ± 1.57</td>
    <td>28.98 ± 1.77</td>
    <td>
     <bold>4.56 ± 0.48</bold>
    </td>
   </tr>
   <tr>
    <td>AML12
     <break/>Selectivity index∗∗
    </td>
    <td>&gt;100 nd</td>
    <td>&gt;100 nd</td>
    <td>&gt;100
     <break/>&gt;2.92
    </td>
    <td>&gt;100 nd</td>
    <td>&gt;100
     <break/>&gt;3.58
    </td>
    <td>&gt;100
     <break/>&gt;3.45
    </td>
    <td>52.90 ± 4.09
     <break/>11.59
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>(∗): The degree of resistance was determined as the ratio of IC
    <sub>50</sub> value in the resistant divided by the IC
    <sub>50</sub> in the sensitive cell line; CEM/ADR5000, MDA-MB-231-
    <italic>BCRP,</italic> HCT116 (
    <italic>p53</italic>
    <sup>
     <italic>−/−</italic>
    </sup>) and U87MG.Δ
    <italic>EGFR</italic> were used as the corresponding resistant counterpart for CCRF-CEM, MDA-MB-231-
    <italic>pcDNA</italic>, HCT116 (
    <italic>p53</italic>
    <sup>
     <italic>+/+</italic>
    </sup>), U87MG respectively; (∗∗): The selectivity index was determined as the ratio of IC
    <sub>50</sub> value in the normal AML12 hepacytes divided by the IC
    <sub>50</sub> in HepG2 hepatocarcinoma cells; In bold: Significant cytotoxic effect [
    <xref rid="bib30" ref-type="bibr">30</xref>, 
    <xref rid="bib34" ref-type="bibr">34</xref>, 
    <xref rid="bib35" ref-type="bibr">35</xref>], The cytotoxicity of compound 
    <bold>7</bold> sitosterol-3-
    <italic>O-β</italic>-
    <sub>D</sub>-glucoside) shown as non-active on these cell lines was previous reported [
    <xref rid="bib8" ref-type="bibr">8</xref>] and this compound was no more tested in this study, Chrysoeriol-7-
    <italic>O</italic>-rutinoside (
    <bold>1</bold>), luteolin-7-
    <italic>O</italic>-rutinoside (
    <bold>2</bold>), chrysoeriol-7-
    <italic>O-β</italic>-
    <sub>D</sub>-glucopyranoside (
    <bold>3</bold>), Apigenin-7-
    <italic>O-β</italic>-
    <sub>D</sub>-glucopyranoside (
    <bold>4</bold>), luteolin-3′,4′-dimethoxylether-7-
    <italic>O-β</italic>-
    <sub>D</sub>-glucoside (
    <bold>5</bold>), luteolin (
    <bold>6</bold>); nd: not determined.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
